Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

ANI Pharmaceuticals Inc (ANIP) Common Stock USD0.0001

Sell:$75.88 Buy:$75.98 Change: $1.29 (1.73%)
NASDAQ:0.91%
Market closed |  Prices as at close on 21 October 2019 | Switch to live prices |
Sell:$75.88
Buy:$75.98
Change: $1.29 (1.73%)
Market closed |  Prices as at close on 21 October 2019 | Switch to live prices |
Sell:$75.88
Buy:$75.98
Change: $1.29 (1.73%)
Market closed |  Prices as at close on 21 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.

Contact details

Address:
210 W Main St
BAUDETTE
56623-2467
United States
Telephone:
+1 (218) 6343500
Website:
www.anipharmaceuticals.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ANIP
ISIN:
US00182C1036
Market cap:
$902.33 million
Shares in issue:
12.10 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Robert Brown
    Independent Chairman of the Board
  • Arthur Przybyl
    President, Chief Executive Officer, Director
  • Stephen Carey
    Chief Financial Officer, Vice President - Finance
  • Robert Schrepfer
    Senior Vice President -New Business Development and Specialty Sales
  • James Marken
    Senior Vice President-Operations and Product Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.